LIFECORE BIOMEDICAL, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
LIFECORE BIOMEDICAL, INC. (LFCR) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $1.19 million as of 2025-05-25, per its 10-K filed 2025-08-07.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2025-08-07
- 2025-05-25: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $1.19M.
- 2024-05-26: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $1.10M.
- 2023-05-28: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $1.00M.
- 2023-02-26: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $900.00K.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2025-05-25 | $1.19M 10-K · filed 2025-08-07 | |
| 2024-05-26 | $1.10M 10-K · filed 2024-08-26 | |
| 2023-05-28 | $1.00M 10-K · filed 2024-03-20 | |
| 2023-02-26 | $900.00K 10-Q · filed 2023-06-02 | |
| 2022-11-27 | $1.00M 10-Q · filed 2023-03-16 | |
| 2022-08-28 | $1.00M 10-Q/A · filed 2023-03-16 | |
| 2022-05-29 | $900.00K 10-K/A · filed 2023-03-16 | |
| 2022-02-27 | $800.00K 10-Q · filed 2022-04-07 | |
| 2021-11-28 | $1.00M 10-Q · filed 2022-01-07 | |
| 2021-08-29 | $1.00M 10-Q · filed 2021-10-05 | |
| 2021-05-30 | $900.00K 10-Q · filed 2022-04-07 | $800.00K 10-K · filed 2021-07-29 |
| 2021-02-28 | $900.00K 10-Q · filed 2021-04-08 | |
| 2020-11-29 | $800.00K 10-Q · filed 2021-01-07 | |
| 2020-08-30 | $800.00K 10-Q · filed 2020-10-07 | |
| 2020-05-31 | $700.00K 10-Q · filed 2021-04-08 | |
| 2020-02-23 | $600.00K 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $600.00K 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $900.00K 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $500.00K 10-Q · filed 2020-04-03 | |
| 2019-02-24 | $538.00K 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $507.00K 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $515.00K 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $372.00K 10-Q · filed 2019-04-04 | |
| 2018-02-25 | $366.00K 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $433.00K 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $495.00K 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $419.00K 10-Q · filed 2018-04-05 | |
| 2017-02-26 | $778.00K 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $764.00K 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $765.00K 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $715.00K 10-Q · filed 2017-04-07 | |
| 2016-02-28 | $727.00K 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $720.00K 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $720.00K 10-Q · filed 2015-10-01 | |
| 2015-05-31 | $800.00K 10-K · filed 2016-08-01 | |
| 2015-03-01 | $800.00K 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $759.00K 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $850.00K 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $817.00K 10-K · filed 2015-07-31 | |
| 2014-02-23 | $827.00K 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $854.00K 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $819.00K 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $807.00K 10-K · filed 2014-08-01 | |
| 2013-02-24 | $785.00K 10-Q · filed 2013-04-04 | |
| 2012-05-27 | $593.00K 10-Q · filed 2013-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |